Understanding the intricate structures and functions of G protein-coupled receptors (GPCRs) like GPR75, a g-protein-coupled receptor, is fundamental to modern drug discovery and life sciences. GPCRs are crucial targets for therapeutic intervention, but determining their high-resolution 3D structures has historically presented significant challenges, particularly for membrane proteins. Fortunately, cutting-edge techniques such as cryo-electron microscopy (cryo-EM), especially Single Particle Analysis (SPA), offer powerful solutions to these challenges. This article explores how cryo-EM, and specifically the capabilities offered by leading platforms, is revolutionizing our understanding of GPR75, a g-protein-coupled receptor, and similar targets.

GPR75 stands out as an important membrane protein and a notable target in the field of structural biology and drug development. As a GPCR, its function involves receiving extracellular signals and transmitting them across the cell membrane, often through interactions with G proteins or other signaling molecules. Unlocking the precise three-dimensional architecture of GPR75, a g-protein-coupled receptor, provides invaluable insights into its ligand binding sites, conformational changes upon activation, and interaction interfaces with downstream effectors. Such detailed structural information is indispensable for rational drug design and optimization.

However, working with membrane proteins like GPR75, a g-protein-coupled receptor, comes with inherent difficulties. These include challenges related to protein expression and purification, maintaining sample stability, overcoming issues like preferential orientation during data collection, dealing with low sample concentrations, and mitigating background noise. These factors have traditionally made obtaining high-resolution structures of membrane proteins difficult using other methods.

Cryo-EM Single Particle Analysis (SPA): A Powerful Tool for GPR75

Cryo-EM Single Particle Analysis (SPA) is a technique uniquely suited to tackle the complexities of membrane protein structure determination. SPA involves collecting extensive 2D images of purified macromolecular particles, such as GPR75, embedded in a thin layer of vitreous ice, which preserves their native state without the need for crystallization. Computational algorithms are then used to process these images and reconstruct a detailed 3D structural model.

The advantages of using cryo-EM SPA for targets like GPR75, a g-protein-coupled receptor, are manifold:

· It preserves samples in a state close to their native condition.

· It can capture diverse conformational states of the protein.

· It often requires minimal sample volume compared to traditional methods.

· It is effective in determining the structure of heterologous protein complexes.

· Crucially for membrane proteins, it allows for the analysis of challenging targets that are difficult to crystallize or work with at high concentrations.

Leading platforms in cryo-EM services recognize the importance of targets like GPR75. For instance, GPR75 is explicitly listed as one of the membrane proteins for which One-Stop SPA Solutions are offered. This indicates a dedicated focus and established workflows for such demanding projects.

Shuimu BioSciences: A One-Stop Solution for GPR75 Research

For researchers focused on GPR75, a g-protein-coupled receptor, accessing comprehensive services that cover the entire workflow from gene sequence to high-resolution structure is critical for minimizing variability and accelerating research. Shuimu BioSciences positions itself as such a "One-Stop" provider, integrating protein expression, purification, and cryo-EM structure determination services.

Their One-Stop SPA Solutions are designed to tackle challenging samples, including membrane proteins like GPR75, g-protein-coupled receptor. The process typically follows a defined workflow: Project Consultation & Discussions, Feasibility Evaluation, Strategy Definition, Contract & Payment, Protein Expression & Purification, Negative Staining (for initial assessment), Sample Freezing & Data Collection, 2D Particle Picking, 3D Reconstruction, Model Refinement, and finally, Data Delivery. This integrated approach ensures a streamlined process and aims to save researchers time and costs.

A key component of this "One-Stop" approach for GPR75 research is the Protein Preparation and Analysis Services. Shuimu offers various protein expression systems, including E. coli, mammalian cells, insect cells, and cell-free systems, allowing them to select the most appropriate system based on the target protein's characteristics and origin. For complex targets like GPR75, which often require post-translational modifications and proper folding inherent to eukaryotic systems, mammalian or insect cell expression might be preferred to ensure biological activity and structural integrity. Shuimu highlights extensive experience in the production and purification of membrane proteins, including GPCRs, ion channels, and transport proteins.

Following expression, proteins like GPR75 undergo rigorous purification using various chromatography methods such as affinity chromatography, ion-exchange chromatography, gel filtration, and reverse-phase HPLC (RP-HPLC). Sample processing can also involve complex incubation, size-exclusion chromatography, gel filtration for higher purity, and other specific steps like Fab fragment generation or phosphorylation analysis depending on the project needs. Protein quality control is performed using techniques like SDS-PAGE, Western blot, mass spectrometry, and thermal stability/solubility testing.

Notably, GPR75 is listed on Shuimu's Off-the-Shelf Protein List, along with other GPCRs, ion channels, and transporters. This suggests that Shuimu has successfully expressed and purified GPR75 previously, potentially offering a faster starting point for structural studies by providing access to pre-validated material. The off-the-shelf list includes different constructs of GPR75, such as GPR75-WT, GPR75-CCL5 N-term fusion, GPR75-15AA switch variants, and GPR75-smBIT fusion, indicating experience with various GPR75 configurations.

Addressing Challenges in GPR75 Structural Studies

Structural studies of membrane proteins like GPR75 are often hampered by issues such as small protein molecular weight, low concentration requirements for Cryo-EM, high background noise, air-water interface disruption, and preferential orientation. Shuimu addresses these challenges through several means:

· GraFuture™ Grids: They have developed a series of graphene support grids, GraFuture™, including Graphene Oxide (GO) and Reduced Graphene Oxide (RGO) versions. These grids are designed to overcome problems like preferred orientation and are suitable for samples with small molecular weight, low concentration, strong background noise, and sensitivity to the air-water interface. Using these specialized grids can significantly improve the quality of cryo-EM data collected for challenging targets like GPR75, a g-protein-coupled receptor.

· AI Algorithms: Shuimu utilizes proprietary AI algorithms, including their independently developed SMART software suite, to streamline cryo-EM data analysis. This AI-driven approach can enhance efficiency and accuracy in structure determination, potentially improving results even from suboptimal data. Their NanoSMART system is specifically designed for analyzing nanoparticle features from low-quality images, which could be relevant for assessing the quality and distribution of purified GPR75 particles.

· Experience and Expertise: Shuimu's team consists of PhD-level experts specializing in structural biology, protein science, and computational biology. Their extensive experience in handling over 200 cryo-EM projects, including membrane proteins like GPR75, and resolving over 150 structures, with a best resolution of 1.8 Å and structures down to 51 kDa, provides the technical know-how to optimize sample preparation and data collection strategies for difficult targets.

State-of-the-Art Infrastructure and Quality

Reliable and high-performance instrumentation is paramount for successful cryo-EM structure determination of targets like GPR75. Shuimu BioSciences has built a significant infrastructure, featuring eight electron microscopes at their Cryo-EM Center, with twelve 300 kV instruments in Beijing and six 300 kV instruments in Hangzhou available for data acquisition. They claim to operate the world's largest commercial cryo-EM platform by instrument count. These instruments are equipped with advanced components like high-performance detectors, energy filters, spherical aberration correctors, and phase plates to ensure imaging quality.

To facilitate efficient research, Shuimu offers 24-hour, round-the-clock instrument access. They maintain their platforms rigorously, with daily maintenance and a focus on optimal operating conditions, ensuring over 330 days of available machine time per instrument annually and a high fault-free operation rate. Professional quality service, experienced technicians, and real-time response further support the data collection process for sensitive samples like purified GPR75.

Proven Track Record and Case Studies

Shuimu BioSciences has a strong track record in resolving challenging protein structures. Since 2017, their platform has completed over 400 cryo-EM projects and resolved over 300 proteins with resolutions below 3.5 Å. They have successfully tackled protein structures as small as 51 kDa and achieved a groundbreaking resolution of 1.4 Å in some cases, continuously pushing the boundaries of the technology.

Specific case sharing mentions successful structure cases resolved by their center, including ion channels and GPCRs. One direct example relevant to GPR75, a g-protein-coupled receptor, is the publication of the cryo-EM complex structure of active GPR75 with a nanobody. This is listed among selected project articles published in top international journals, demonstrating their capability in determining complex structures involving GPCRs. While detailed insights into the GPR75 structure from this specific case are not provided in the source other than its mention, its inclusion highlights Shuimu's practical experience and success with this particular target. Their success in resolving structures of other GPCRs, such as histamine H1 receptor, D1 dopamine receptor, κ-opioid receptor, and somatostatin receptors, further underscores their expertise in this class of membrane proteins.

Sample Submission for GPR75 Structural Studies

To initiate a cryo-EM study of GPR75, a g-protein-coupled receptor, potential clients would need to prepare and submit samples according to specific requirements. For protein solutions intended for SPA, key requirements include a concentration of ≥ 2 mg/mL, a volume of ≥ 100 µL, and purity of ≥ 90%. Recommendations are made to reduce modifications like glycosylation or phosphorylation if possible, minimize freeze-thaw cycles, and ideally use freshly prepared samples. The buffer solution should minimize organic solvents like glycerol and have a salt ion concentration ≤ 300 mM.

If protein expression and purification are required first, plasmid requirements include purity > 90%, concentration > 100 ng/µL, and a total amount > 1 µg, along with vector information. For samples prepared by the Shuimu EM platform, reserving machine time in advance and providing sample preparation conditions are necessary. Cryo-samples should be delivered at least one working day in advance, potentially via liquid nitrogen tanks. These detailed requirements are designed to ensure optimal sample quality for successful cryo-EM data collection and structure determination of challenging targets like GPR75.

Conclusion

Cryo-EM technology, particularly SPA, has become an indispensable tool for determining the high-resolution structures of complex biological macromolecules, including challenging membrane proteins like GPR75, a g-protein-coupled receptor. Understanding the 3D structure of GPR75 is crucial for gaining insights into its function and facilitating the development of targeted therapies.

Platforms offering comprehensive "One-Stop" solutions, combining expertise in protein science, cryo-EM technology, and advanced data analysis, are essential partners in accelerating this research. Shuimu BioSciences, with its extensive experience in membrane protein production, state-of-the-art cryo-EM infrastructure, dedicated team of experts, proprietary AI tools, and a proven track record including successful projects on GPR75 and other GPCRs, is well-equipped to support researchers in resolving the structures of demanding targets. Their ability to overcome common challenges such as low sample concentration and preferential orientation through innovations like GraFuture™ grids further enhances their capability for targets like GPR75, a g-protein-coupled receptor.

For researchers seeking to determine the structure of GPR75 or other GPCRs, partnering with an experienced platform providing integrated services and advanced technological solutions is a key step towards success.

To learn more about how cryo-EM can advance your research on GPR75, a g-protein-coupled receptor, or other challenging targets, please visit https://shuimubio.com/.

Discover the potential of high-resolution structural insights for your drug discovery or life science project by exploring the services offered at https://shuimubio.com/.